At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Mar 19, 2026 at 18:57 ET
Anthony Mancini, an insider at Revolution Medicines, exercised options for 74,900 shares and sold 1,800 shares on the open market for $167,801. The majority of the transaction value comes from non-cash derivative exercises, with only a small portion representing actual open-market selling.
- Anthony Mancini exercised options for 74,900 shares in two tranches of 37,450 shares each, one at $0 and one at $33.62 per share, resulting in a total cost of $1,259,069.
- Mancini sold 1,800 shares on the open market for $167,801 at an average price of $93.223.
- The total open-market sale represents approximately 0.0009% of Revolution Medicines' $18.7B market cap, well below the 0.1% threshold for materiality.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access